huCART19-IL18

CAR-T cell therapy expressing IL-18 targeting CD19 · University of Pennsylvania

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for huCART19-IL18, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: huCART19-IL18 in CD19+ Cancers [Phase 1]